In breast cancer cells, exosomal (mi)RNA released by cancer-associated fibroblasts enhance tumor growth, metastasis, and therapeutic resistance [62,63]; whereas cancer cells-derived exosomal miR-105 promotes tumor growth through MYC proto-oncogene (MYC)-dependent metabolic reprogramming of stromal cells [64]. The gene discussed is MYC; the disease is neoplasm.